PerkinElmer, Inc. (NYSE:PKI) Director Peter Barrett sold 7,071 shares of PerkinElmer stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $71.07, for a total value of $502,535.97. Following the completion of the sale, the director now owns 26,271 shares in the company, valued at $1,867,079.97. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Shares of PerkinElmer, Inc. (NYSE PKI) traded down $0.06 during trading hours on Tuesday, reaching $71.27. The company’s stock had a trading volume of 512,100 shares, compared to its average volume of 633,650. The stock has a market capitalization of $7,862.36, a PE ratio of 25.66, a price-to-earnings-growth ratio of 2.01 and a beta of 0.77. PerkinElmer, Inc. has a 1-year low of $49.72 and a 1-year high of $73.05. The company has a quick ratio of 2.09, a current ratio of 2.59 and a debt-to-equity ratio of 0.44.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Friday, January 19th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date is Thursday, January 18th. PerkinElmer’s payout ratio is 7.78%.

TRADEMARK VIOLATION WARNING: This story was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/11/14/perkinelmer-inc-pki-director-sells-502535-97-in-stock.html.

A number of large investors have recently made changes to their positions in the business. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in PerkinElmer by 0.4% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,175 shares of the medical research company’s stock valued at $557,000 after buying an additional 31 shares during the last quarter. ING Groep NV raised its stake in PerkinElmer by 0.6% during the second quarter. ING Groep NV now owns 6,057 shares of the medical research company’s stock valued at $413,000 after buying an additional 38 shares during the last quarter. CIBC Asset Management Inc raised its stake in PerkinElmer by 0.4% during the second quarter. CIBC Asset Management Inc now owns 9,549 shares of the medical research company’s stock valued at $651,000 after buying an additional 40 shares during the last quarter. LS Investment Advisors LLC raised its stake in PerkinElmer by 2.1% during the second quarter. LS Investment Advisors LLC now owns 2,877 shares of the medical research company’s stock valued at $196,000 after buying an additional 60 shares during the last quarter. Finally, Tributary Capital Management LLC raised its stake in PerkinElmer by 0.3% during the second quarter. Tributary Capital Management LLC now owns 22,300 shares of the medical research company’s stock valued at $1,520,000 after buying an additional 75 shares during the last quarter. Institutional investors and hedge funds own 91.54% of the company’s stock.

A number of brokerages have recently weighed in on PKI. Piper Jaffray Companies reiterated a “buy” rating and issued a $81.00 price objective on shares of PerkinElmer in a research report on Friday, August 4th. Citigroup Inc. restated a “buy” rating and set a $80.00 price target (up from $74.00) on shares of PerkinElmer in a research report on Tuesday, September 26th. Cowen and Company restated a “hold” rating and set a $70.00 price target on shares of PerkinElmer in a research report on Friday, September 1st. BidaskClub lowered PerkinElmer from a “buy” rating to a “hold” rating in a research report on Friday, July 28th. Finally, Zacks Investment Research upgraded PerkinElmer from a “hold” rating to a “buy” rating and set a $78.00 price target on the stock in a research report on Wednesday, July 19th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and six have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $68.64.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Insider Buying and Selling by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.